Naringin abrogates HIV-1 protease inhibitors-induced atherogenic dyslipidemia and oxidative stress in vivo
Protective effects of naringin against HIV-1 protease inhibitors (PIs)-induced dyslipidemia and oxidative stress were investigated in vivo. Male Wistar rats were orally treated daily with atazanavir {ATV; 133 mg/kg body weight (BW)}, saquinavir (SQV; 333 mg/kg BW), distilled water (3.0 ml/kg BW) and...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2019-01-01
|
| Series: | Journal of Functional Foods |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1756464618305760 |